Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Circassia gets US and Chinese rights to AIT's pulmonary hypertension system

Executive Summary

AIT Therapeutics Inc. licensed Circassia Pharmaceuticals PLC commercial rights in the US and China to its AirNOvent cylinder free nitric oxide (NO) generator and phasic-flow delivery system for use in treating persistent pulmonary hypertension of the newborn (PPHN) and related indications in the hospital setting.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Includes Equity
    • Intra-Biotech Deal
    • Includes Royalty or Profit Split Information

Related Companies